In conclusion, we have discovered a unique mechanism for BCL9 which is, the formation of BCL9/PS-727-STAT3 complexes on enhancers and subsequent transcription of target genes involved in driving DCIS invasive progression. Here, BCL9 is linked to ductal breast carcinoma in situ.